Status: Recruiting

Phase III Clinical Trial of STSP-0601 for Injection in Hemophilia Patients

This study will assess the efficacy of multiple-dose of STSP-0601 for the treatment of bleeding episodes in hemophilia A or B patients with inhibitor

Participants needed: 40

Trial details

Phase: Phase 3Age: 12-70Biological sex: AllType: InterventionalSponsor: Jiangsu BioJeTay Biotechnology Co., Ltd.Updated: Apr 23, 2026Locations: 18

Eligibility criteria

12 ≤age≤70 years of age. [+6]

Have any coagulation disorder other than hemophilia. [+14]

Status: Recruiting

A Phase Ib/II Clinical Trial of Multiple Doses of STSA-1301 Subcutaneous Injection in Healthy Subjects and Patients With Immune Thrombocytopenia (ITP)

A randomized, double-blind, placebo-controlled design was designed to evaluate the safety and tolerability, pharmacokinetic/pharmacodynamic profile, and immunogenicity of multiple administration of STSA-1301 subcutaneous injection in healthy subjects and patients with ITP, and to further explore the initial efficacy of STSA-1301 subcutaneous injection in patients with ITP

Participants needed: 56

Trial details

Phase: Phase 1, Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Jiangsu BioJeTay Biotechnology Co., Ltd.Updated: Jan 16, 2026Locations: 7

Eligibility criteria

18 years ≤ age ≤ 50 years, male or female subjects; [+12]

Subject has a history of serious medical conditions (including, but not limited... [+37]

Clinical trials

Phase III Clinical Trial of STSP-0601 for Injection in Hemophilia Patients

A Phase Ib/II Clinical Trial of Multiple Doses of STSA-1301 Subcutaneous Injection in Healthy Subjects and Patients With Immune Thrombocytopenia (ITP)